ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CYBG Ve Bionic Etf

17.063
0.102 (0.60%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Ve Bionic Etf LSE:CYBG London Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.102 0.60% 17.063 16.966 17.156 17.22 17.061 17.22 1,300 16:35:28

RBS Reports Loss, to Miss Long-Term Targets

28/10/2016 8:40am

Dow Jones News


Ve Bionic Etf (LSE:CYBG)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ve Bionic Etf Charts.

LONDON—Royal Bank of Scotland Group PLC said it may miss its long-term financial goals after slumping to a net loss in the third quarter partly on a provision for U.S. legal settlements.

The bank, 73% owned by the British government, said on Friday it fell to a £ 469 million ($570.3 million) loss in the three months to end-September from a £ 960 million profit in the same period last year. Revenue was up slightly at £ 3.3 billion from £ 3.1 billion in the third quarter last year.

The British bank incurred several one-off items including a £ 425 million legal provision, mainly related to settlements with U.S. authorities over the sale of mortgage-backed securities.

The bank signaled that it was unlikely to meet long-term financial targets because of low interest rates.

"We now don't expect to achieve these by 2019 as previously indicated," the bank said in a statement.

The bank also confirmed that it won't meet a 2017 deadline to separate its Williams & Glyn unit. The bank must dispose of Williams & Glyn by the end of 2017 to meet European state aid rules following RBS's bailout in 2008. Earlier this week CYBG PLC said that it has made a preliminary nonbinding proposal for the branches. RBS is now in discussion with the U.K. Treasury on how to proceed with negotiations with the European Commission.

Problems at Williams & Glyn would push expected restructuring charges up by £ 500 million for the year, RBS said.

The bank spent £ 469 million on restructuring its business in the quarter. It also wrote down the value of its deferred tax assets.

"The timing of returning excess capital to shareholders through dividends or buybacks remains uncertain," the bank said in a statement.

Write to Max Colchester at max.colchester@wsj.com

 

(END) Dow Jones Newswires

October 28, 2016 03:25 ET (07:25 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.

1 Year Ve Bionic Etf Chart

1 Year Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

1 Month Ve Bionic Etf Chart

Your Recent History

Delayed Upgrade Clock